Greiner Michael's Form 4 filing
Avanos Medical, Inc. (AVNS) · filed Mar 15, 2024
- Accession no.
- 0001606498-24-000045
- Filed
- Mar 15, 2024
- Trade date
- Mar 14, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $153.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Greiner MichaelCIK 0001520392 | Officer (SVP - Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | Common Stock | SSaleDisposed | −3,800 | $19.11 | −$72,618 | 155,695 | Direct | |
| Mar 14, 2024 | Common Stock | SSaleDisposed | −714 | $19.12 | −$13,651.68 | 154,981 | Direct | |
| Mar 14, 2024 | Common Stock | SSaleDisposed | −2,231 | $19.13 | −$42,679.03 | 152,750 | Direct | |
| Mar 14, 2024 | Common Stock | SSaleDisposed | −337 | $19.14 | −$6,450.18 | 152,413 | Direct | |
| Mar 14, 2024 | Common Stock | SSaleDisposed | −808 | $19.15 | −$15,473.2 | 151,605 | Direct | |
| Mar 14, 2024 | Common Stock | SSaleDisposed | −110 | $19.16 | −$2,107.6 | 151,495 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
On January 2, 2023, March 4, 2023 and May 7, 2023, a total of 61,472 time-based restricted share units held by the Reporting Person vested (the Vested TRSUs). On March 14, 2024, the Reporting Person completed the sale of 8,000 shares of the Issuer's common stock. The Reporting Person has advised the Issuer that: (i) he intends to use the proceeds from the sale of such shares to satisfy the tax obligations resulting from the vesting of the Vested TRSUs and (ii) he was not in possession of material non-public information regarding the Issuer at the time of such sale.